Oscar Health (NYSE:OSCR) Trading Up 3.6%

Oscar Health, Inc. (NYSE:OSCR) shares were up 3.6% during trading on Wednesday . The stock traded as high as $22.82 and last traded at $22.71. Approximately 490,009 shares changed hands during trading, a decline of 85% from the average daily volume of 3,231,363 shares. The stock had previously closed at $21.93.

Analysts Set New Price Targets

Several research analysts have commented on OSCR shares. Wells Fargo & Company boosted their price objective on shares of Oscar Health from $24.00 to $27.00 and gave the company an “overweight” rating in a research report on Wednesday, June 12th. Baird R W upgraded shares of Oscar Health to a “strong-buy” rating in a research report on Thursday, May 30th. Bank of America reiterated a “neutral” rating and set a $21.00 price target (down from $25.00) on shares of Oscar Health in a report on Thursday, May 30th. Robert W. Baird assumed coverage on shares of Oscar Health in a report on Thursday, May 30th. They set an “outperform” rating and a $28.00 price target for the company. Finally, Piper Sandler reiterated an “overweight” rating and set a $28.00 price target on shares of Oscar Health in a report on Tuesday, September 10th. Two equities research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $24.17.

Oscar Health Trading Up 2.6 %

The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.26. The company has a market cap of $5.44 billion, a P/E ratio of -56.57, a PEG ratio of 41.60 and a beta of 1.61. The firm’s 50 day moving average is $17.51 and its two-hundred day moving average is $17.42.

Oscar Health (NYSE:OSCR) last issued its quarterly earnings data on Wednesday, August 7th. The company reported $0.20 earnings per share for the quarter, topping the consensus estimate of $0.16 by $0.04. Oscar Health had a net margin of 0.25% and a return on equity of 1.86%. The company had revenue of $2.20 billion for the quarter, compared to analysts’ expectations of $2.13 billion. During the same quarter in the previous year, the firm posted ($0.07) earnings per share. Oscar Health’s revenue for the quarter was up 44.6% on a year-over-year basis. As a group, equities research analysts anticipate that Oscar Health, Inc. will post 0.01 EPS for the current year.

Insider Buying and Selling

In other Oscar Health news, insider Mario Schlosser sold 3,198 shares of the company’s stock in a transaction on Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total transaction of $57,532.02. Following the sale, the insider now owns 76,982 shares of the company’s stock, valued at $1,384,906.18. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other Oscar Health news, insider Mario Schlosser sold 3,198 shares of the company’s stock in a transaction on Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total transaction of $57,532.02. Following the sale, the insider now owns 76,982 shares of the company’s stock, valued at $1,384,906.18. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CAO Victoria Baltrus sold 4,226 shares of the company’s stock in a transaction on Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total transaction of $76,025.74. Following the sale, the chief accounting officer now directly owns 140,648 shares in the company, valued at approximately $2,530,257.52. The disclosure for this sale can be found here. Insiders have sold a total of 169,569 shares of company stock valued at $3,007,069 over the last 90 days. 25.11% of the stock is owned by insiders.

Hedge Funds Weigh In On Oscar Health

Several institutional investors have recently made changes to their positions in the stock. Vanguard Group Inc. raised its holdings in shares of Oscar Health by 2.4% in the 1st quarter. Vanguard Group Inc. now owns 14,582,762 shares of the company’s stock worth $216,846,000 after acquiring an additional 337,850 shares during the last quarter. Formation8 GP LLC acquired a new stake in shares of Oscar Health in the 4th quarter worth about $47,480,000. Price T Rowe Associates Inc. MD raised its holdings in shares of Oscar Health by 153.5% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 3,978,152 shares of the company’s stock worth $59,156,000 after acquiring an additional 2,409,160 shares during the last quarter. Renaissance Technologies LLC raised its holdings in shares of Oscar Health by 31.7% in the 2nd quarter. Renaissance Technologies LLC now owns 3,886,100 shares of the company’s stock worth $61,478,000 after acquiring an additional 934,600 shares during the last quarter. Finally, Dimensional Fund Advisors LP raised its holdings in shares of Oscar Health by 14.2% in the 4th quarter. Dimensional Fund Advisors LP now owns 3,162,935 shares of the company’s stock worth $28,942,000 after acquiring an additional 392,837 shares during the last quarter. Institutional investors and hedge funds own 75.70% of the company’s stock.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.